These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 828444)

  • 1. Treatment of lupus nephritis.
    Pollak VE
    Adv Nephrol Necker Hosp; 1976; 6():137-61. PubMed ID: 828444
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of treatment of lupus nephropathy.
    Coggins CH
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):197-200. PubMed ID: 7102668
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of lupus-nephritis using corticosteroids and immunosuppressive agents].
    Kampf D; Baethke R
    Dtsch Med Wochenschr; 1974 Jun; 99(26):1420-3. PubMed ID: 4135099
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controlled trial of cyclophosphamide, azathioprine and chlorambucil in lupus nephritis (the double-blind method)].
    Ivanova MM; Nasonova VA; Solov'ev SK; Akhnazarova VD; Speranskiĭ AI
    Vopr Revm; 1981; (2):11-8. PubMed ID: 7034366
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical course of lupus nephritis: relationship to the renal histologic findings.
    Pollak VE; Pirani CL; Dujovne I; Dillard MG
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1167-81. PubMed ID: 4139685
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of treatment in lupus nephritis: effects of prednisone.
    Pollak VE; Dosekun AK
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):170-7. PubMed ID: 7102665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus nephritis: long-term follow-up.
    Cameron JS; Jones MB
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1187-91. PubMed ID: 4215066
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lupus nephritis: treatment with intravenous pulses of methylprednisolone and cyclophosphamide].
    Giganti J; Eimon A; Frega N; Hübscher O; Arana RM
    Medicina (B Aires); 1984; 44(2):219-20. PubMed ID: 6537461
    [No Abstract]   [Full Text] [Related]  

  • 11. [Morphological and immunohistochemical changes in the kidneys and skin in systemic lupus erythematosus during the course of treatment].
    Gritsman NN; Akhnazarova VD; Ivanova MM; Solov'ev SK
    Revmatologiia (Mosk); 1983; (2):41-5. PubMed ID: 6353514
    [No Abstract]   [Full Text] [Related]  

  • 12. Clonality of the spontaneous immune response to DNA in murine lupus.
    Cavallo T; Granholm NA; Graves K; Izui S
    J Clin Lab Immunol; 1986 Jun; 20(2):81-7. PubMed ID: 3488408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term course of 32 cases of diffuse proliferative lupus glomerulonephritis, treated with corticoids alone or combined with cyclophosphamide].
    Jungers P; Dougados M; Tron F; Leibowitch J; Lesavre P; Droz D; Bach JF
    J Urol Nephrol (Paris); 1979 Dec; 85(12):855-8. PubMed ID: 554871
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic lupus erythematosus--immunoregulatory therapies.
    Miller ML; Steinberg AD
    Clin Rheum Dis; 1983 Dec; 9(3):617-28. PubMed ID: 6360516
    [No Abstract]   [Full Text] [Related]  

  • 15. High dose intravenous corticosteroid therapy of systemic lupus erythematosus and primary cresenteric rapidly progressive glomerulonephritis. Proceedings of a symposium. Helsinki, September 16th, 1983.
    Scand J Rheumatol Suppl; 1984; 54():1-33. PubMed ID: 6592748
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
    Heras M; Saiz A; Fernández-Reyes MJ; Sánchez R; Zurita P; Urrego C
    Nefrologia; 2011; 31(2):231-3. PubMed ID: 21461001
    [No Abstract]   [Full Text] [Related]  

  • 17. Lupus nephritis: clinical course in relation to treatment.
    Nanra RS; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1193-210. PubMed ID: 4803309
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of ultrahigh doses of corticosteroids in treating the most severe variants of lupus nephritis].
    Ianushkevich TN; Klepikov PV
    Ter Arkh; 1990; 62(6):50-3. PubMed ID: 2218927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of cytotoxic immunosuppressive agents on the level of urinary seromucoids and cathepsins in lupus nephritis].
    Stepanova NS; Solov'ev SK; Kaĭnova AS; Ivanova MM
    Ter Arkh; 1980; 52(6):116-9. PubMed ID: 7404377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.